NEW YORK (GenomeWeb) – Columbia University Medical Center's Laboratory of Personalized Genomic Medicine has received final approval from the New York State Department of Health for its diagnostic whole-exome sequencing test for inherited disorders after submitting its application a year and a half ago.

Demand for the exome test, as well as for a targeted diagnostic sequencing test called the Columbia Combined Genetic Panel, has grown over the past year as clinicians from different specialties are getting more familiar with the new options, according to lab representatives.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.

Sep
17
Sponsored by
SeraCare

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.